← Back to Search

Bariatric Surgery

Weight Loss Surgery Outcomes for Obesity

N/A
Recruiting
Led By Michael Feizbakhsh, MD
Research Sponsored by Dr. Feiz & Associates
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 0, 1, 3, 6, 12 months
Awards & highlights

Study Summary

This trial looks at how weight loss surgery affects quality of life in low-risk patients with BMI <35 and no co-morbidities.

Who is the study for?
This trial is for individuals with a BMI between 30 and 34.5 who are healthy enough for cosmetic weight loss surgery but don't have other health issues like diabetes or high blood pressure. Participants must be able to give informed consent and follow study procedures.Check my eligibility
What is being tested?
The study aims to assess patient-reported outcomes after weight loss surgery in low-risk patients, focusing on changes in health, mood, quality of life, satisfaction with their health status, and emotional well-being.See study design
What are the potential side effects?
Since the intervention involves questionnaires about body image and self-esteem rather than medical treatments, there are no direct physical side effects from participating in this trial.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~0, 1, 3, 6, 12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 0, 1, 3, 6, 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in Perception of Body Image
Change in Perception of General Health
Change in Perception of Quality of Life

Trial Design

1Treatment groups
Experimental Treatment
Group I: Patients with BMI between 30-34.5 kg/m2Experimental Treatment1 Intervention
Patients with BMI between 30-34.5 kg/m2 will be administered a body image/self-esteem questionnaire pre-operatively and at 1 month, 3 months, 6 months and 12 months post-operatively.

Find a Location

Who is running the clinical trial?

Dr. Feiz & AssociatesLead Sponsor
Michael Feizbakhsh, MDPrincipal InvestigatorDr. Feiz and Associates

Media Library

Weight Loss Surgery (Bariatric Surgery) Clinical Trial Eligibility Overview. Trial Name: NCT05699083 — N/A
Weight Loss Research Study Groups: Patients with BMI between 30-34.5 kg/m2
Weight Loss Clinical Trial 2023: Weight Loss Surgery Highlights & Side Effects. Trial Name: NCT05699083 — N/A
Weight Loss Surgery (Bariatric Surgery) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05699083 — N/A
Weight Loss Patient Testimony for trial: Trial Name: NCT05699083 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the cap on participant enrollment for this experiment?

"Affirmative. Clinicaltrials.gov data demonstrate that this study, which was first launched on March 11th 2022, is currently taking in patients. The trial requires 20 participants to register from one location."

Answered by AI

Are vacancies still available for the participants in this experiment?

"Affirmative, the clinicaltrials.gov listing has this trial actively searching for applicants. Initially advertised on March 11th 2022, it was last updated January 24th 2023 and is looking to enrol a total of 20 patients at one location."

Answered by AI

Who else is applying?

What state do they live in?
Tennessee
California
What site did they apply to?
Dr. Feiz and Associates
What portion of applicants met pre-screening criteria?
Met criteria
How many prior treatments have patients received?
0

Why did patients apply to this trial?

I tried working out. I am looking for an effective wieght loss program or trial.
PatientReceived no prior treatments
very interested in weight loss and maintaining the lost of weight in a healthy manner.
PatientReceived no prior treatments

What questions have other patients asked about this trial?

how soon before you will have in office screening for this study...?
PatientReceived no prior treatments
~5 spots leftby Jan 2025